Delivery Order SPE2DB20D2104-SPE2DB25FMXVU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5 milliliter units, with a ceiling value of $1,749.30 and firm fixed pricing. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $2,125.04 delivery order to AmerisourceBergen Drug Corp for Trumenba 120 MCG/0.5 ML vaccine on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract is classified as a delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,918.20 to AmerisourceBergen Drug Corp for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5-milliliter doses. This firm fixed-price delivery order was competitively awarded with no set-aside designation and has an ultimate completion date of January 6, 2026. The vaccine will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $1,097.44 delivery order to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price. The award was executed on June 2, 2025, with an ultimate completion date of June 3, 2025, and performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,125.04 for TRUMENBA 120MCG (meningococcal B vaccine) on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and is being performed at the company's Conshohocken, PA facility. This delivery order falls under the Defense Logistics...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,872.68 to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. This non-set-aside, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a procurement of pharmaceutical products supporting the federal...
- This delivery order, valued at $1,264.96, was awarded to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trumenba 120 MCG/0.5 ML vaccine in 0.5 ML quantities. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), with performance to be completed by April 25, 2025, and fulfillment at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml doses. The firm-fixed-price delivery order has a ceiling value of $2,887.80 and an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.72 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCINE 0.5ML, a vaccine product. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXVUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,062.52 to AmerisourceBergen Drug Corp for the supply of Trumenba (meningococcal vaccine B) 120 mcg/0.5 mL doses on August 14, 2025, with completion targeted for August 15, 2025. The order represents a firm fixed price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026. This child contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its extensive federal contract portfolio. The Trumenba vaccine delivery supports DLA's medical supply chain requirements and aligns with the agency's broader pharmaceutical prime vendor program, which supplies medications, vaccines, and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order exemplifies the routine pharmaceutical supply transactions conducted under the company's prime IDC, demonstrating its established capability to meet federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/14/25 |